|Description||Cysteamine is an agent for the treatment of nephropathic cystinosis and an antioxidant. It has been shown to increase intracellular glutathione levels in cystinotic cells, thus restoring the altered redox state of the cells and increased rates of apoptosis in cystinotic cells, which are thought to be the result of increased caspase 3 and protein kinase Cε activity. Cysteamine has antioxidant properties as a result of increasing glutathione production.|
|Synonyms||Cysteamine; Cystagon; L 1573; L-1573; L1573; NSC 647528; NSC-647528; NSC647528; β-MEA; β-Mercaptoethylamine; 2-Aminoethanethiol; 2-Mercaptoethylamine; Decarboxycysteine; Thioethanolamine|
Parimifasor is an immunomodulator that exhibits anti-inflammatory activity. It is a potential therapy for inflammatory bowel disease (IBD).
BMS-505130 is a potent and selective serotonin transport inhibitor with K(i) of 0.18 nM.
Z-ASTD-FMK is a cell-permeant and irreversible inhibitor of endothelial monocyte-activated polypeptide II (EMAP II).
D-AP4 has been found to be an excitatory amino acid receptor antagonist as well as an agonist at the quisqualate-sensitized AP6 site.
Buspirone is a serotonergic (5HT(1A) receptor agonist) anxiolytic drug with some D(2) dopaminergic effect, used for anxiety disorders.
CGP 3466B maleate
CGP 3466B maleate, a potent anti-apoptotic drug, is an orally active glyceraldehyde-3-phosphate dehydrogenase (GAPDH) inhibitor. CGP 3466B maleate was tested in...
LY 140091 is a bio-active chemical, but no detailed information has been published yet.
GSK-1071306 is one of the metabolites of pazopanib which is a inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity as a approve...